Is RPG Life Sciences a good company?

RPG Life Sciences is certified as. One of India’s 100 Best Companies to Work For 2020 & One of India’s Best Workplaces in Biotechnology & Pharmaceuticals by. Great Place to Work® Institute.

Is Caris an NGS test?

Next-Generation Sequencing (NGS): Caris has one of the most advanced sequencing laboratories in the world, enabling Whole Exome (DNA) and Whole Transcriptome (RNA) sequencing on every patient.

Is Caris Life Sciences a good company?

Is Caris Life Sciences a good company to work for? Caris Life Sciences has an overall rating of 2.8 out of 5, based on over 142 reviews left anonymously by employees. 51% of employees would recommend working at Caris Life Sciences to a friend and 57% have a positive outlook for the business.2022-05-01

What is Caris MPI Inc?

Caris provides cancer patients and oncologists with reliable, high-quality, comprehensive molecular information to deliver on the promise of precision medicine.

What kind of company is Caris Life Sciences?

molecular science company

Is Caris testing FDA approved?

Caris Molecular Intelligence has not been approved by the United States Food and Drug Administration. Please consult your physician to determine if Caris Molecular Intelligence® is right for you.

What is Caris testing?

Caris Molecular Intelligence performs comprehensive molecular testing on the DNA, RNA and Proteins to identify the biomarkers driving a patient’s tumor. This information may be a powerful tool to aid oncologists in personalizing cancer therapies for their patients.

How long does it take to get Caris results?

Our Comprehensive Tumor Profiling approach to tumor profiling assess DNA, RNA and Proteins to reveal a molecular blueprint to guide more precise and individualized treatment decisions. With results back in about 8 days, we’ll help you find better answers when you need it most.

How much is Caris Life Sciences worth?

$7.83 billion

What is Caris MPI?

The first of its kind, Caris Molecular Intelligence is a unique tool that combines comprehensive tumor testing with the latest clinical research on biomarkers to provide your doctor with timely information to evaluate potential treatment options. Better information can lead to better treatment decisions.

What is Caris treatment?

The technology. Caris Molecular Intelligence (CMI, Caris Life Sciences) is a solid tumour biomarker analysis service. It is intended as a tool to aid decision-making and help identify the best treatment plan for each patient.2017-09-20

What is Mi profile by Caris?

MI Profile is a multi-platform, solid tumor biomarker analysis for therapeutic decision support and clinical trials matching.

Are liquid biopsies available?

Although standard tissue biopsies generally involve invasive procedures to detect a tumor, liquid biopsies are performed on peripheral blood which is easy to access, allowing for more widespread use, particularly in patients who cannot have surgery.2021-10-11

Does Caris test for HRD?

IRVING, Tex., June 5, 2017 Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today announced results of a molecular profiling analysis to identify the frequency of Homologous Recombination Deficiencies (HRD) from approximately 53,000 tumors.2017-06-05

When was Caris Life Sciences founded?

Founded in 2008, Caris Life Sciences® is on a mission to help patients, clinicians, researchers, and payors navigate, advance and reinvent cancer care.

What genes are associated with HRD?

Scientists have known that HRD may be found in ovarian tumors with BRCA1 and BRCA2 gene mutations, but they’re also discovering that tumors without those mutations may also have HRD. Besides ovarian cancer, HRD may be found in other cancers, including: Breast cancer.2021-07-22

Is Caris going public?

According to the Wall Street Journal, which first reported on the raise, Caris expects to complete their IPO sometime within the next 12 months. Caris’ strategy utilizes artificial intelligence to map a cancer patient’s genetic makeup and determine which kinds of treatments would be best suited for an optimal outcome.2021-05-12

How many genes does Caris test?

RNA sequencing, to identify fusions and rearrangements of 53 genes.2017-09-20

What is Mi tumor seek?

_______________________________________________________________________________________________________ MI Tumor Seek is a Next-Generation Sequencing (NGS)-based tumor profiling assay that covers DNA mutations, copy number alterations, insertions/deletions, and RNA fusions for select lineages.

Caris Life Sciences Stock / Share Price, Funding Rounds

Caris Life Sciences stock price, funding rounds, valuation and financials Caris Life Sciences has raised $1.14 b in total funding. Caris Life Sciences valuation is $7.8 b, View Company Get notified regarding key financial metrics and revenue changes at Caris Life Sciences Learn more Caris Life Sciences Funding Summary Metrics

Invest or Sell Caris Life Sciences Stock – SharesPost

Caris Life Sciences Stock Enterprise Value (based on primary financings) View Enterprise Value for Caris Life Sciences. Register Today Team Management Team David Halbert Co-Founder, Chairman and Chief Executive Officer David Spetzler Ph.D President & Chief Scientific Officer Thomas Parker Chief Financial Officer and Senior Vice President

Caris Life Sciences Inc – Company Profile and News

Caris Life Sciences, Inc. operates as a biotechnology company. The Company specializes in pathology, molecular profiling, and microvesicle technology for the diagnosis and treatment of cancerous

Caris HealthCare LP – Company Profile and News – Bloomberg

Stocks Currencies Commodities Rates & Bonds Sectors Watchlist Recently Viewed Companies Caris HealthCare LP Caris HealthCare LLP provides elderly care. The Company helps to maintain quality of life

Caris Life Sciences Raises $830 Million in Growth Equity

IRVING, Texas, /PRNewswire/ — Caris Life Sciences ®, a leading innovator in molecular science and artificial intelligence (AI) focused on fulfilling the promise of precision medicine,

Curis, Inc. (CRIS) Stock Price, News, Quote & History

curis, inc. (nasdaq: cris), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that on april 1, 2022, the independent

Caris Life Sciences Acquires Pharmatech | Markets Insider

Headquartered in Irving, Texas, Caris Life Sciences offers services throughout the U.S., Europe, Asia and other international markets. To learn more, please visit www.CarisLifeSciences.com or

Caris Life Sciences Gets $830 Million Investment From

Caris Life Sciences has received an $830 million infusion from a group led by Sixth Street Partners, the companies said, the latest sign of private equity’s enthusiasm for investing at the

Bloomberg: Genetic-Sequencing Firm – Caris Life Sciences

The following article appeared in Bloomberg: Genetic-Sequencing Firm CEO With Jack Welch Aura Mulls New IPO. Cristin Flanagan. June 6, 2018. David Halbert says he never missed or lowered his forecasts as the former head of a publicly traded company and grew earnings per share for investors quarter after quarter. Immediately, one of the Street’s most celebrated […]

READ Is it hard to get into SDSU nursing program?

Revolutionizing Cancer Care | Caris Life Sciences

Caris Life Sciences is a leading innovator in molecular science, helping patients, clinicians, researchers, and payors navigate, advance and reinvent cancer care. Our core competencies span multiple critical aspects of the life sciences industry: Molecular Profiling 101 DNA and RNA Sequencing Biopharma Solutions Tumor Biomarker Analysis

Caris Life Sciences Raises $830 Million in Growth Equity

Caris Life Sciences®, a leading innovator in molecular science and artificial intelligence (AI) focused on fulfilling the promise of precision medicine, announced an $830 million growth equity

Claris Life Share Price, Claris Life Stock Price, Claris

ATHANAS ENTERPRISES PRIVATE LIMITED Qty 23780172 Price 204.7 % Traded 43.58 30 Dec, 2013 ATHANAS ENTERPRISES PRIVATE LIMITED Qty 7800507 Price 219.1 % Traded 14.30 30 Dec, 2013 ABELLON ENERGY

Caris Life Sciences Company Profile: Funding & Investors

Caris Life Sciences General Information Description. Operator of a biotechnology company specializing in cancer treatment. The company is focused on molecular science and artificial intelligence to offer precision medicine and facilitating an understanding of cancer biology and other complex diseases through profiling offerings to assess DNA, RNA and proteins that reveal the molecular

Caristocks | News,Stock Price,Data From Jamaica Stock

Caristocks | News,Stock Price,Data From Jamaica Stock Exchange and Caribbean Financial Market Caristock | is you guide tracking the Caribbean Financial Markets such as Jamaica stock exchange

Home – Curis, Inc

About Curis is a biotechnology company focused on the development and commercialization of innovative therapeutics for the treatment of cancer. We currently have three drug candidates in development: Fimepinostat (formerly known as CUDC-907), an orally available, small molecule inhibitor of HDAC and PI3K enzymes being investigated in a Phase 2 clinical trial in patients with […]

Caris Molecular Intelligence Tumor Profiling – Enabling

Caris Life Sciences will bill the patient’s insurance company, and the patient is typically responsible for co-payments, co-insurance and/or the deductible, as required by law. Depending on the profile ordered, the number of markers analyzed and technologies used, the cost will differ among the various tumor profiling options.

StarStock

The stock market For sports cards. Instant trading. Instant ownership on purchase. Day-trading on game day is now possible! Save time selling. We photograph and categorise your collection. You just list your price. Invest at scale. Purchase from multiple sellers in a single transaction. No fees for buyers.

Caris' Precision Oncology Alliance Welcomes Loma Linda

IRVING, Texas, May 5, 2022 /PRNewswire/ — Caris Life Sciences® (Caris), the leading molecular science and technology company actively developing and delivering innovative solutions to

Working at Caris Life Sciences: 89 Reviews | Indeed.com

89 reviews from Caris Life Sciences employees about Caris Life Sciences culture, salaries, benefits, work-life balance, management, job security, and more.

Home – Carris Reels, Inc.

Carris Reels is an employee-owned, customer driven company specializing in the production of wood, metal and recycled reels, including Reelex accessories.

Buy or sell Cruise stock pre IPO via an – EquityZen

Cruise Stock Self-driving car company Founded 2013 Notable Investors General Motors Headquarters San Francisco CA, US Total Funding $5.3B About Cruise Stock Cruise is building the world’s most advanced self-driving vehicles to safely connect people with the places, things, and experiences they care about.

Caris Life Sciences Publishes New Data in Clinical Cancer

Caris provides services throughout the U.S., Europe, Asia and other international markets. To learn more, please visit www.CarisLifeSciences.com or follow us on Twitter (@CarisLS). Caris Life

Caris Life Sciences – Funding, Financials, Valuation

Funding. Caris Life Sciences has raised a total of $1.3B in funding over 5 rounds. Their latest funding was raised on Oct 1, 2021 from a Venture – Series Unknown round. Caris Life Sciences is funded by 19 investors. Empede Capital and Coatue are the most recent investors.

Caris considers IPO after landing $310M – Dallas Business

While Caris has been investing, it’s been stepping up efforts with its locations. The company is expanding its physical reach as it adds 115,000 square feet of laboratory and office space in the

Merus and Caris Life Sciences Announce Collaboration to

Caris to provide DNA and RNA molecular testing to support patient identification and enrollment for Merus’ Zenocutuzumab Phase 1/2 eNRGy trial. UTRECHT, The Netherlands and CAMBRIDGE, Mass. and IRVING, Texas, (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq: MRUS), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics

Chancery OKs $24M Settlement In Caris Stock Option Dispute

Law360, Wilmington (, 8:25 PM EDT) — A Delaware Chancery judge on Wednesday approved a $24 million settlement between former Caris Life Sciences employees and Caris’ successor

Careers – Carris Reels, Inc.

At Carris Reels, all employee-owners are invested in more than one way. Equitable pay and above average benefits are part of the equation, as are monthly incentives and annual profit-sharing bonuses. One hundred percent of the company’s stock is held in an Employee Stock Ownership Plan (ESOP) which is a defined contribution retirement plan.

Caris' Precision Oncology Alliance Welcomes Loma Linda

Caris Life Sciences® (Caris) is the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize healthcare and improve patient outcomes.

Zentalis Pharmaceuticals and Caris Life Sciences Announce

Caris Life Sciences ® (Caris) is the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize healthcare and improve patient outcomes. Through comprehensive molecular profiling (Whole Exome and Whole Transcriptome Sequencing) and the application of advanced artificial

Caris Life Sciences Receives FDA Breakthrough Device

Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following

Caris Life Sciences Raises $310 Million in Growth Capital

Caris Life Sciences Raises $310 Million in Growth Capital from a Broad Syndicate of Leading Investors Caris will continue its rapid growth in the expansive precision medicine market through its

READ Is it better to run 3 or 4 days a week?

CURI Stock Price | CuriosityStream Inc. Stock Quote (U.S

CURI | Complete CuriosityStream Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Buy or sell Cruise stock pre IPO via an – EquityZen

About Cruise Stock. Cruise is building the world’s most advanced self-driving vehicles to safely connect people with the places, things, and experiences they care about. Cruise autonomous vehicles are on the road in San Francisco navigating some of the most challenging and unpredictable driving environments, because the best way to bring self

Bill Gates Portfolio List | All 21 Stock Investments Now

Bill Gates Portfolio List | All 21 Stock Investments Now. Updated on December 28th, 2021 by Bob Ciura. Bill Gates is the fourth-richest person in the world, behind only Jeff Bezos, Elon Musk, and Bernard Arnault. While Bill Gates has fallen to #4, his net worth of ~$124 billion is a massive amount of money. Not surprisingly, the Bill & Melinda

Cardi's Furniture & Mattresses | Shop by Room & Get Inspired

Shop by room or for the entire home with furniture from Cardi’s. We have several convenient locations, financing, & protection plans. Try our room planner.

10 Best Health Care Stocks to Buy for 2022 | Investing

Bank of America has a “buy” rating and $522 price target for UNH stock, which closed at $494.13 on Dec. 22. Pfizer Inc. ( PFE ) Pfizer is one of the world’s largest pharmaceutical companies.

KRISTIN PHILLIPS v. CARIS LIFE SCIENCES INCORPORATED

Plaintiff-Appellant Kristin Phillips (“Phillips”) brought suit against Caris Life Sciences, Inc., and Miraca Life Sciences, Inc. (hereinafter “Caris”), alleging a hostile work environment, sex discrimination, and retaliation under Title VII of the Civil Rights Act of 1964, 42 U.S.C. § 2000e et seq. Caris moved for summary judgment on

CAR-Macrophage Therapy | CAR-Macrophages | Carisma

A unique therapeutic approach. Carisma Therapeutics is pioneering the development of CAR-Macrophages, a disruptive approach to immunotherapy. Our technology leverages advances in macrophage biology, chimeric antigen receptor engineering, and adoptive cellular therapy for the treatment of human disease.

Caris Life Sciences – Crunchbase Company Profile & Funding

Caris Life Sciences was founded with a very simple but powerful purpose – to help improve the lives of as many. people as possible. Through tireless efforts, breakthrough molecular science, and a passionate commitment to quality, they remain steadfastly focused on the most important part of their work – the patient.

‎Caris على App Store

‎Caris – Trợ lý ảo giao thông – chỉ dẫn và cảnh báo bằng giọng nói, đảm bảo người lái ôtô luôn tuân thủ luật giao thông & lái xe an toàn.

How Tumor Profiling Works – Caris Molecular Intelligence

Caris Life Sciences Reviews – Glassdoor

Caris Life Sciences has an overall rating of 2.8 out of 5, based on over 139 reviews left anonymously by employees. 51% of employees would recommend working at Caris Life Sciences to a friend and 58% have a positive outlook for the business. This rating has decreased by -13% over the last 12 months.

Caris' Precision Oncology Alliance Welcomes The University

Caris Life Sciences® (Caris) is the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize healthcare and improve patient outcomes.

Delaware Court Awards Damages to Option Holders

At that point, Caris (owning only Caris Diagnostics) merged into a subsidiary of Miraca. Most of the equity in Caris not owned by Halbert or JH Whitney (2.9%) consisted of stock options that were cancelled in connection with the Miraca transaction, with each holder having the right to receive for each covered share the amount by which the

Caris LeVert returns to Brooklyn with Cavaliers

Caris LeVert arrives to the arena before the game against the Nets. LeVert is one of only three Cavaliers players with playoff experience, along with Kevin Love and Rajon Rondo. Even if it is only

Caris Says Chancery Wrongly Backed Workers' Stock Claims

Caris Life Sciences argued Friday in a brief before the Delaware Supreme Court that the Chancery Court wrongly found the company purposefully lowballed its two businesses’ value before a 2011

Caris Life Sciences Secures $310 Million to Advance

Molecular science company Caris Life Sciences secured $310 million in growth capital that will be used to expand its presence in precision medicine in oncology.. This morning, Texas-based Caris announced the funding, which includes $235 million in equity financing, will be used to support its ongoing oncology focus, as well as to accelerate the development of innovative therapeutics and

Caris Life Sciences Launches HLA Genotype Reporting, the

About Caris Life SciencesCaris Life Sciences® is a leading innovator in molecular science and artificial intelligence focused on fulfilling the promise of precision medicine through quality and

Caris' Precision Oncology Alliance Welcomes The University

Caris Life Sciences Media Contact: Ann Obeney Vice President, Corporate Communications [email protected] 469-550-1589. Markey Cancer Center Media Contact: Mallory Olson Public Relations Officer

Hawaii News Archive – Starbulletin.com

Caris tops local stock pickers in turbulent year. By . POSTED: Sunday, . The stock market was a bloodbath in 2008. Norm Caris. Caris and Co. Position: Managing director for institutional sales . 12/31 return: -13.2% . Barry Hyman

Caris Life Sciences – Advanced-Online

Caris incurred expenses for rental storage units to store inventory without reliable inventory management processes or cost controls in place. Problems resulting were over-ordering of inventory, loss of print materials version, and incomplete shipments due to stock-outs.

Netflix: The Slide Continues; Caris Downgrades Rating

Contributing to the ongoing pressure on the stock: Caris & Co. analyst David Miller this morning cut his rating on the stock to Average from Above Average, with a new target of $185, down from $322.

Peter Caris Photos and Premium High Res – Getty Images

Find the perfect Peter Caris stock photos and editorial news pictures from Getty Images. Select from premium Peter Caris of the highest quality.

National HealthCare buys outstanding interest in Caris

National HealthCare (NYSE: NHC) acquired the remaining interest in hospice and palliative care provider Caris Healthcare, L.P. from Norman C. The commercial terms were not disclosed. Caris

READ Is Dispatch a magazine?

ESSA Pharma (EPIX) and Caris Life Sciences Cooperating on

What’s Going on with ESSA Pharma Inc.?. ESSA Pharma Inc. and Caris Life Sciences will collaborate on a Precision Development program, which is being designed to support ESSA’s “ongoing clinical development of EPI-7386” as a treatment for prostate cancer.Yesterday, Oct. 6, EPIX stock closed at $7.95 per share, representing a 9.04% drop in price.

299 Salaries at Caris Life Sciences Shared by – Glassdoor

The average Caris Life Sciences salary ranges from approximately $62,108 per year for a Molecular Technologist to $104,035 per year for an Account Manager.The average Caris Life Sciences hourly pay ranges from approximately $19 per hour for a Laboratory Operations Specialist to $29 per hour for a Molecular Technologist.Caris Life Sciences employees rate the overall compensation and benefits

Caris Tiivel High Resolution Stock Photography and Images

Find the perfect caris tiivel stock photo. Huge collection, amazing choice, 100+ million high quality, affordable RF and RM images. No need to register, buy now!

Simple Homemade Vegetable Stock | Lauren Caris Cooks

To make the Vegetable Stock. 1. Thoroughly wash all the vegetables. We aren’t going to peel them so make sure they are extra clean. Chop all the vegetables into 1/2 inch chunks. 2. Add some olive oil into a large pot and heat over a medium heat. Add the vegetables and saute for 5-10 minutes until they begin to soften.

Auction Prices Realized Basketball Cards 2019 Panini Hoops

2019 Panini Hoops Premium Stock. 8,750. Sales $673,574. Value Auction Price Totals. PRICES POP APR REGISTRY SHOP Grades (Click to show Caris LeVert Pulsar: 15: Caris LeVert: 15: Caris LeVert Gold Pulsar: 15: Caris LeVert Silver Prizm: 15: Caris LeVert Blue Prizm: 15: Caris LeVert Green Prizm: 15:

Pacers: 2 best Caris LeVert trades ahead of NBA trade deadline

With their season going nowhere, the Indiana Pacers are conducting a fire sale ahead of the February 10 trade deadline. The Pacers have made Domantas Sabonis, Myles Turner, and Caris LeVert on the

EMC: Caris Upgrades; Says The Stock Is Too Cheap To Ignore

EMC (EMC) shares are getting a boost this morning from Caris analyst Robert Cihra, who upgraded the storage hardware company’s stock to Buy from Average, with a new target of $24, up from $23.

Caris Life Sciences and ESSA Pharma Announce Liquid Biopsy

Caris Life Sciences ® (Caris) is a molecular science company developing and delivering technologies to revolutionize healthcare. The Company’s suite of market-leading molecular profiling offerings assesses DNA, RNA and proteins to reveal a molecular blueprint that helps patients, physicians and researchers improve outcomes and save lives.

NBA scout on injured Caris LeVert and the draft: 'His

NBA scout on injured Caris LeVert and the draft: ‘His stock is hurt’ Sean Deveney • 3 min read. SANTA CRUZ, Calif. — It had been a strange season for Michigan wing Caris LeVert. And the foot

Why Bionano Genomics Stock Rocketed More Than 28% Today

Why Bionano Genomics Stock Rocketed More Than 28% Today By Joe Tenebruso – at 4:19PM You’re reading a free article with opinions that may differ from The Motley Fool’s Premium

Caris Tiivel Photos and Premium High Res Pictures – Getty

Browse 63 caris tiivel stock photos and images available, or start a new search to explore more stock photos and images. Ex Miss Universe Australia, model Caris Tiivel from Perth on board Cunard’s Queen Mary 2 on in Melbourne, Australia. Ex Miss Universe Australia, model Caris Tiivel from Perth on board Cunard’s Queen Mary 2

Daniel Magee's research works | Caris Life Sciences, Texas

Daniel Magee’s 27 research works with 46 citations and 696 reads, including: Molecular alterations across sites of metastasis in patients with renal cell carcinoma (RCC).

Caris' Google Earnings Preview: Still Our #1 Internet

Caris & Company analyst Tim Boyd addresses clients on Google’s (NASDAQ:NASDAQ:GOOG) upcoming quarterly report, for the quarter ending June 2006.

EPIX PHARMACEUTICALS (EPIX) – ESSA Pharma, Caris Life

Caris Life Sciences and ESSA Pharma Inc (NASDAQ: EPIX) have announced a Precision Development program to support ESSA’s development of EPI-7386 in metastatic castration-resistant prostate cancer

2019-20 Hoops Premium Stock Basketball Checklist, Release

2019-20 Hoops Premium Stock Basketball Checklist – Utah Jazz. 33 Jordan Clarkson. 79 Bojan Bogdanovic. 124 Emmanuel Mudiay. 185 Donovan Mitchell. 186 Mike Conley. 187 Rudy Gobert. 188 Joe Ingles.

Youth Indiana Pacers Caris LeVert City Edition Mixtape

Limited Stock. Youth Indiana Pacers Caris LeVert City Edition Mixtape Swingman Jersey by Nike. SKU: 9930300492-45%. Zoomed in Youth Indiana Pacers Caris LeVert City Edition Mixtape Swingman Jersey by Nike images. This is a carousel of product images. Use Next and Previous buttons to navigate and the Close button to close the dialog

NHC National HealthCare Corporation Stock Quote

A Sliding Share Price Has Us Looking At National HealthCare Corporation’s (NYSEMKT:NHC) P/E Ratio. Simply Wall St. +10.24%. Mar-06-20 03:47PM. National HealthCare Corporation Announces Support for, and Compliance with, CMS and CDC Requirements and Guidelines for Infection Control. Business Wire.

In Brief This Week: Ginkgo Bioworks, Caris Life Sciences

Caris Life Sciences said this week that the Caris Precision Oncology Alliance and NCI’s Center for Cancer Research will collaborate on precision medicine research initiatives. company also said this week that its board has declared a regular quarterly dividend of $.07 per share of common stock, payable on , to all shareholders

Caris LeVert flipped for Victor Oladipo in – New York Post

The trades didn’t stop after the Nets’ blockbuster for James Harden. After it was reported that the Nets were shipping Caris LeVert to the Rockets, Jarrett Allen and Taurean Prince to t…

Caris LeVert – NBADraft.net

Caris LeVert poised for a breakout season – UM Hoops/Joe Stapleton: 10/28/2013 With bulked-up role and frame, LeVert shines – The Michigan Daily/Daniel Feldman: 10/30/2013 New-look Michigan squad coasts to easy exhibition victory – The Detroit News/Rod Beard: 10/30/2013